Clinical Trials on SIRS(Systemic Inflammatory Response Syndrome) in Switzerland

Total 516 results

Luzerner Kantonsspital
St. Joseph's Healthcare Hamilton; University Hospital Inselspital, Berne; Erasmus... and other collaborators

Unknown

Neonatal Procalcitonin Intervention Study (NeoPInS)

Sepsis

Switzerland
University Hospital, Geneva

Completed

Procalcitonin-Guided Antimicrobial Discontinuation

Sepsis

Switzerland
Ospedale Regionale Bellinzona e Valli
Brahms SA, D-16761 Hennigsdorf bei Berlin

Completed

Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With Corticosteroids

Sepsis

Switzerland
Hannover Medical School
CytoSorbents, Inc

Recruiting

Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS) (CYTORELEASE)

Cytokine Release Syndrome | CAR-T

Germany, Switzerland
University Hospital Inselspital, Berne

Completed

Mitochondrial Function of Immune Cells in Sepsis (MitoSepsis)

Shock, Septic

Switzerland
University of Zurich

Unknown

Acute Phase Proteins as Early Markers in Sepsis

Sepsis

Switzerland
University Hospital, Basel, Switzerland

Completed

Clinical Impact of Rapid Identification of Positive Blood Cultures vs. Internal Laboratory Standard

Bloodstream Infections

Switzerland
University Hospital, Basel, Switzerland
Swiss Personalized Health Network (SPHN); Personalized Health and Related Technologies...

Recruiting

Personalized Swiss Sepsis Study (PSSS_digital)

Sepsis

Switzerland
University Hospital, Basel, Switzerland
Fresenius AG

Completed

BaSES Trial: Basel Starch Evaluation in Sepsis (BaSES)

Sepsis | Septic Shock | Severe Sepsis

Switzerland
University of Zurich
Triemli Hospital; Kantonsspital Münsterlingen; Waid City Hospital, Zurich

Not yet recruiting

Sevoflurane Sedation in Patients With Septic Shock (SSiS)

Shock, Septic

Switzerland
University Hospital Inselspital, Berne

Completed

Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland

Bacteremia

Switzerland
University of Zurich

Unknown

Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration

Bacteremia

Switzerland
University of Zurich

Completed

Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients (Vit B12)

Bacteremia

Switzerland
hemotune AG

Not yet recruiting

First in Human Trial to Assess the Safety & Efficacy of HemoSystem REBOOT in Patients With Sepsis-induced Immunosuppression (RESTORE I)

Septic Shock

Switzerland
University Hospital Inselspital, Berne

Terminated

Comparison of a Tissue Perfusion Guided Hemodynamic Protocol With a Standard Hemodynamic Protocol in Septic Shock Patients

Septic Shock

Switzerland
University Hospital, Geneva

Terminated

Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery

Surgery | Severe Sepsis | Emergency

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Protocolised Early De-Resuscitation in Septic Shock (REDUCE) (REDUCE)

Septic Shock

Switzerland
University of Zurich

Completed

The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study (ENDoX-study)

Patients in Septic Shock

Switzerland
University Hospital, Geneva

Recruiting

Muscle Ultrasound Study in Shock Patients (MUSiShock)

Septic Shock

Switzerland
Abionic SA

Completed

Early Diagnostic of Sepsis and Potential Impact on Antibiotic Management Based on Serial.Pancreatic Stone Protein (PSP) Measured Using the AbioScope.

Sepsis

France, Italy, Switzerland, United Kingdom
Helsinki University Central Hospital
University Hospital Inselspital, Berne

Completed

Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock (TARTARE-2S)

Critical Illness | Shock; Septic

Finland, Switzerland
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Personalized Immunotherapy in Sepsis (ImmunoSep)

Sepsis

Greece, Germany, Netherlands, Romania, Switzerland
MeMed Diagnostics Ltd.
University Hospital, Geneva

Completed

Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source

Infectious Disease | Fever | Viremia

Switzerland
University of Zurich

Completed

PVP Iodine Effect on Post Debridement Bacteraemia (PJB 1)

Bacteraemia Post Debridement

Switzerland
Resistell AG
Innosuisse - Swiss Innovation Agency

Completed

Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis (NANO-RAST)

Bacteremia Sepsis

Switzerland
Luzerner Kantonsspital

Completed

Procalcitonin-Guided Decision Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis

Sepsis

Switzerland
University Hospital, Basel, Switzerland

Completed

Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital Infection

Bloodstream Infection (BSI)

Switzerland
University of Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois; Cantonal Hospital of St. Gallen

Completed

Antibiotic Durations for Gram-negative Bacteremia (PIRATE)

Bacteraemia Caused by Gram-Negative Bacteria

Switzerland
Societe Française de Medecine d'urgence

Completed

SEPSIS 3 Critera for Risk Stratification in Emergency Patients (SCREEN)

Sepsis | Emergency

France, Switzerland, Belgium, Spain
Hannover Medical School

Not yet recruiting

Efficacy of add-on Plasma Exchange as an Adjunctive Strategy Against Septic Shock (EXCHANGE-2)

Septic Shock

Switzerland, Austria, Germany
University Hospital Inselspital, Berne

Completed

Inflammatory Response in Aortic Valve Replacement

Systemic Inflammatory Response Syndrome | Inflammation | Aortic Valve Stenosis | Thoracic Surgery

Switzerland
University Hospital, Basel, Switzerland

Completed

Septic Encephalopathy and Late Cognitive Dysfunction

Sepsis | Severe Sepsis

Switzerland
University Hospital Freiburg
University Hospital, Basel, Switzerland

Completed

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

Bacterial Infections | Bacteremia | Catheter-Associated Infections | Catheterization, Central Venous

Germany, Switzerland
Eli Lilly and Company

Completed

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

Sepsis

United States, United Kingdom, France, Slovakia, Switzerland, Australia, Poland, Italy, Chile, Germany, Mexico
University Hospital, Bonn

Unknown

Surveillance for Nosocomial Infections in Pediatric Cancer Patients (Oncoped2006)

Invasive Aspergillosis | Bloodstream Infection | Nosocomial Infections

Switzerland
Anders Perner
Rigshospitalet, Denmark; Scandinavian Critical Care Trials Group; Centre for...

Active, not recruiting

The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial (CLASSIC)

Septic Shock

Sweden, Denmark, Belgium, Czechia, Italy, Norway, Switzerland, United Kingdom
Resistell AG

Recruiting

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia (PHENOTECH-1)

Bacteremia Sepsis

Austria, Spain, Switzerland
Radboud University Medical Center
Horizon 2020 - European Commission

Recruiting

Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia

Candidemia

Netherlands, United States, Switzerland, Germany, Romania, Greece
Eli Lilly and Company

Completed

The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis

Sepsis

United States, Canada, Brazil, Mexico, Australia, Czech Republic, Slovakia, Spain, Austria, Belgium, Chile, Denmark, Egypt, Finland, France, Germany, India, Italy, Lebanon, Netherlands, New Zealand, Norway, Romania, Russian Federation, Saudi... and more
Santersus AG
ISS AG

Not yet recruiting

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating cfDNA/NETs in Subjects With Sepsis (NUC-CAP)

Sepsis | Respiratory Failure

United Kingdom, Germany, Switzerland
University Hospital, Geneva
European Society of Intensive Care Medicine; Swiss National Fund for Scientific... and other collaborators

Completed

Defects in Opsonophagocytosis in Premature Infants

Prematurity | Neonatal Sepsis

Switzerland
Emma Marie Caroline Slack
University of Zurich; University Children's Hospital, Zurich

Completed

Characterization of Intestinal Microbiota Stability in Preterm Born Neonates (NEC)

Late-Onset Neonatal Sepsis | Necrotising Enterocolitis

Switzerland
University Hospital, Geneva
University of Geneva, Switzerland

Completed

Understanding COVID-19

SARS-CoV-2 Viral Kinetics and Host Immune Responses

Switzerland
Eisai Inc.

Completed

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Severe Sepsis

United States, France, Poland, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Switzerland, Argentina, Belgium, Israel, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Australia, Chile, Brazil, Austria, Italy, Czechia, Portug...
Pfizer

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

Candidiasis | Fungemia

Belgium, United States, Canada, Switzerland, Netherlands, Bulgaria, Portugal, Romania, Russian Federation
University Hospital, Basel, Switzerland
Swiss Personalized Health Network (SPHN); Personalized Health and Related Technologies...

Terminated

Molecular Biomarkers for Sepsis

Sepsis | Infection, Bacterial | Severe Community-acquired Pneumonia (sCAP)

Switzerland
Eli Lilly and Company

Completed

Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock

Sepsis

Italy, United Kingdom, United States, Germany, Spain, Belgium, France, Australia, Czech Republic, Netherlands, Canada, Mexico, New Zealand, Finland, Portugal, Brazil, India, Switzerland
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Sunnybrook Health Sciences Centre

Completed

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE)

Sepsis | Mortality | Bacteremia | Critically Ill | Intensive Care | Antimicrobial

New Zealand, United States, Canada, Australia, Switzerland, Saudi Arabia, Israel
University of Zurich

Unknown

Differential EBI2 Expression Upon Allelic Status of the rs9557195 Polymorphism

Inflammatory Bowel Diseases

Switzerland

Clinical Trials on SIRS(Systemic Inflammatory Response Syndrome) in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations